Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $1.66 billion. The enterprise value is $1.39 billion.
| Market Cap | 1.66B |
| Enterprise Value | 1.39B |
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 85.98 million shares outstanding. The number of shares has decreased by -9.71% in one year.
| Current Share Class | 85.98M |
| Shares Outstanding | 85.98M |
| Shares Change (YoY) | -9.71% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 1.48% |
| Owned by Institutions (%) | 96.29% |
| Float | 79.58M |
Valuation Ratios
The trailing PE ratio is 33.13 and the forward PE ratio is 11.12. Progyny's PEG ratio is 1.20.
| PE Ratio | 33.13 |
| Forward PE | 11.12 |
| PS Ratio | 1.35 |
| Forward PS | 1.25 |
| PB Ratio | 3.20 |
| P/TBV Ratio | 3.40 |
| P/FCF Ratio | 8.74 |
| P/OCF Ratio | 8.23 |
| PEG Ratio | 1.20 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.16, with an EV/FCF ratio of 7.29.
| EV / Earnings | 26.10 |
| EV / Sales | 1.12 |
| EV / EBITDA | 17.16 |
| EV / EBIT | 18.06 |
| EV / FCF | 7.29 |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.70 |
| Quick Ratio | 2.62 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.34 |
| Debt / FCF | 0.15 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.94% and return on invested capital (ROIC) is 9.41%.
| Return on Equity (ROE) | 10.94% |
| Return on Assets (ROA) | 6.57% |
| Return on Invested Capital (ROIC) | 9.41% |
| Return on Capital Employed (ROCE) | 14.20% |
| Revenue Per Employee | $1.83M |
| Profits Per Employee | $78,124 |
| Employee Count | 680 |
| Asset Turnover | 1.70 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $36.11 million in taxes.
| Income Tax | 36.11M |
| Effective Tax Rate | 40.47% |
Stock Price Statistics
The stock price has increased by +16.72% in the last 52 weeks. The beta is 1.34, so Progyny's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | +16.72% |
| 50-Day Moving Average | 22.00 |
| 200-Day Moving Average | 21.95 |
| Relative Strength Index (RSI) | 36.44 |
| Average Volume (20 Days) | 1,709,132 |
Short Selling Information
The latest short interest is 7.04 million, so 8.18% of the outstanding shares have been sold short.
| Short Interest | 7.04M |
| Short Previous Month | 6.87M |
| Short % of Shares Out | 8.18% |
| Short % of Float | 8.84% |
| Short Ratio (days to cover) | 6.55 |
Income Statement
In the last 12 months, Progyny had revenue of $1.24 billion and earned $53.12 million in profits. Earnings per share was $0.58.
| Revenue | 1.24B |
| Gross Profit | 277.44M |
| Operating Income | 76.77M |
| Pretax Income | 89.23M |
| Net Income | 53.12M |
| EBITDA | 80.79M |
| EBIT | 76.77M |
| Earnings Per Share (EPS) | $0.58 |
Balance Sheet
The company has $305.09 million in cash and $28.63 million in debt, giving a net cash position of $276.46 million or $3.22 per share.
| Cash & Cash Equivalents | 305.09M |
| Total Debt | 28.63M |
| Net Cash | 276.46M |
| Net Cash Per Share | $3.22 |
| Equity (Book Value) | 515.02M |
| Book Value Per Share | 6.04 |
| Working Capital | 373.98M |
Cash Flow
In the last 12 months, operating cash flow was $202.00 million and capital expenditures -$11.80 million, giving a free cash flow of $190.20 million.
| Operating Cash Flow | 202.00M |
| Capital Expenditures | -11.80M |
| Free Cash Flow | 190.20M |
| FCF Per Share | $2.21 |
Margins
Gross margin is 22.34%, with operating and profit margins of 6.18% and 4.28%.
| Gross Margin | 22.34% |
| Operating Margin | 6.18% |
| Pretax Margin | 7.18% |
| Profit Margin | 4.28% |
| EBITDA Margin | 6.51% |
| EBIT Margin | 6.18% |
| FCF Margin | 15.31% |
Dividends & Yields
Progyny does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 9.71% |
| Shareholder Yield | n/a |
| Earnings Yield | 3.19% |
| FCF Yield | 11.44% |
Analyst Forecast
The average price target for Progyny is $26.50, which is 37.02% higher than the current price. The consensus rating is "Buy".
| Price Target | $26.50 |
| Price Target Difference | 37.02% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 8.92% |
| EPS Growth Forecast (5Y) | 32.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Progyny has an Altman Z-Score of 7.33 and a Piotroski F-Score of 7.
| Altman Z-Score | 7.33 |
| Piotroski F-Score | 7 |